FDA NDC Directory · JSON-LD · Markdown

Guaifenesin

NDC 65162-036 · HUMAN OTC DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA207342
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsGUAIFENESIN (600 mg/1)
Marketing started20180727
Package count3

External sources

Source: openFDA. Public-domain (CC0).